Kliniske forsøg sponsoreret af Cancer Institute and Hospital, Chinese Academy of Medical Sciences
I alt 2245 resultater
-
Academy Military Medical Science, ChinaCancer Institute and Hospital, Chinese Academy of Medical SciencesUkendt
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringMavekræft | Diffus type karcinomKina
-
Cancer Institute and Hospital, Chinese Academy...Rekruttering
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringHoved- og halskræftKina
-
Cancer Institute and Hospital, Chinese Academy...Rekruttering
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringLokalt avanceret ikke-småcellet lungekræftKina
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringLungekræft | Ikke småcellet lungekræft | Lunge Adenocarcinom | Småcellet lungekræft | LungepladecellekarcinomKina
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringHepatocellulært karcinom | Strålebehandling | Smal MarginKina
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringKemoterapeutisk toksicitet | Strålebehandling; Komplikationer | PARP-hæmmer | Immun Checkpoint Inhibitor | Trastuzumab | Brystkræft, familiær mand | CDK4/6 hæmmer | PertuzumabKina
-
Cancer Institute and Hospital, Chinese Academy...Rekruttering
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringLokalt avanceret kolorektalt karcinomKina
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringRefraktære faste tumorer | Recidiverende solide tumorerKina
-
Cancer Institute and Hospital, Chinese Academy...Ikke rekrutterer endnuKræft | Kateterkomplikationer | Trombose, venøsKina
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringTilbagevenden | Kirurgi | Kræft i skjoldbruskkirtlenKina
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringTilbagevenden | Kræft i skjoldbruskkirtlenKina
-
Cancer Institute and Hospital, Chinese Academy...Ikke rekrutterer endnu
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringBevacizumab | Capecitabin | Metastatisk kolorektal cancer (mCRC) | Oxaliplatin | Tislelizumab | Første linje | MSS/pMMR | RAS-muteretKina
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringVaccine mod covid-19 | Covid-19-infektionKina
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringBrystkræft | Bivirkning til strålebehandlingKina
-
Cancer Institute and Hospital, Chinese Academy...Rekruttering
-
Cancer Institute and Hospital, Chinese Academy...Rekruttering
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringHoved- og halskræft | StrålingsdermatitisKina
-
Cancer Institute and Hospital, Chinese Academy...Rekruttering
-
Cancer Institute and Hospital, Chinese Academy...Rekruttering
-
Cancer Institute and Hospital, Chinese Academy...Rekruttering
-
Cancer Institute and Hospital, Chinese Academy...Ikke rekrutterer endnu
-
Cancer Institute and Hospital, Chinese Academy...Ikke rekrutterer endnuStrålebehandling | Rektale neoplasmer ondartedeKina
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringMetastatisk nasopharyngeal cancerKina
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringHormonreceptor positiv avanceret brystkræftKina
-
Cancer Institute and Hospital, Chinese Academy...Rekruttering
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringLivmoderhalskræft i spiserøretKina
-
Cancer Institute and Hospital, Chinese Academy...Ikke rekrutterer endnu
-
Cancer Institute and Hospital, Chinese Academy...Ikke rekrutterer endnuKolorektal cancer stadium IV | Hånd og fod hudreaktionKina
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringMaligne kolorektale neoplasmerKina
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringBlødt vævssarkom | Bivirkning til strålebehandling | Retroperitoneal sarkom | Ultrahypofraktioneret strålebehandling | Stereotaktisk ablativ strålebehandlingKina
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringProstatakræft | Bivirkning til strålebehandling | Oligometastatisk sygdom | Magnetisk resonans-linac | Stereotaktisk ablativ RT | Adaptiv strålebehandling | Lokaliseret sygdomKina
-
Cancer Institute and Hospital, Chinese Academy...Ikke rekrutterer endnuLivmoderhalskræft Stadium IB1Kina
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringAnlotinib | Sarkom, blødt væv | Bagagerum | Ekstremitet | Intensitetsmoduleret strålebehandling | Større sårkomplikationerKina
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringMetastatisk triple-negativ brystkræftKina
-
Cancer Institute and Hospital, Chinese Academy...Rekruttering
-
Cancer Institute and Hospital, Chinese Academy...Ikke rekrutterer endnu
-
Cancer Institute and Hospital, Chinese Academy...Ikke rekrutterer endnu
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringKemoradiation | Kemoterapi effekt | Immunterapi | Målrettet terapi | Spiserørskræft | Esophagogastric Junction CancerKina
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringSmåcellet lungekarcinomKina
-
Cancer Institute and Hospital, Chinese Academy...Ikke rekrutterer endnu
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringEsophageal pladecellekarcinomKina
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringSpiserørskræft | Ikke-operable ondartet neoplasma | Kemoradioterapi | NimotuzumabKina
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringTilbagevendende nasopharyngeal karcinom | Metastatisk nasopharyngeal karcinomKina
-
Cancer Institute and Hospital, Chinese Academy...Afsluttet
-
Cancer Institute and Hospital, Chinese Academy...Afsluttet